AGEN Agenus Inc

Price (delayed)

$2.56

Market cap

$523.99M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.05

Enterprise value

$479.85M

Sector: Healthcare
Industry: Biotechnology

Highlights

The quick ratio has increased by 22% YoY
The EPS has declined by 31% year-on-year but it is up by 3.7% since the previous quarter
AGEN's equity is up by 10% YoY but it is down by 2.6% QoQ
Agenus's debt has surged by 138% YoY and by 52% QoQ
AGEN's net income has shrunk by 68% YoY and by 4.4% QoQ

Key stats

What are the main financial stats of AGEN
Market
Shares outstanding
204.69M
Market cap
$523.99M
Enterprise value
$479.85M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
5.01
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.44
Earnings
Revenue
$88.17M
EBIT
-$119.84M
EBITDA
-$112.66M
Free cash flow
-$142.56M
Per share
EPS
-$1.05
Free cash flow per share
-$0.83
Book value per share
-$1.07
Revenue per share
$0.51
TBVPS
$1.03
Balance sheet
Total assets
$214.51M
Total liabilities
$426.01M
Debt
$55.73M
Equity
-$203.67M
Working capital
-$16.1M
Liquidity
Debt to equity
-0.27
Current ratio
0.88
Quick ratio
0.78
Net debt/EBITDA
0.39
Margins
EBITDA margin
-127.8%
Gross margin
97.3%
Net margin
-205.2%
Operating margin
-131.6%
Efficiency
Return on assets
-92.3%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-141.6%
Return on sales
-135.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AGEN stock price

How has the Agenus stock price performed over time
Intraday
-2.29%
1 week
-4.48%
1 month
-17.42%
1 year
-4.83%
YTD
-19.5%
QTD
-5.88%

Financial performance

How have Agenus's revenue and profit performed over time
Revenue
$88.17M
Gross profit
$85.82M
Operating income
-$116.01M
Net income
-$180.91M
Gross margin
97.3%
Net margin
-205.2%
Agenus's net margin has shrunk by 186% YoY and by 8% QoQ
AGEN's operating income has dropped by 80% year-on-year and by 10% since the previous quarter
AGEN's net income has shrunk by 68% YoY and by 4.4% QoQ
The gross profit has contracted by 43% YoY and by 4.5% from the previous quarter

Growth

What is Agenus's growth rate over time

Valuation

What is Agenus stock price valuation
P/E
N/A
P/B
N/A
P/S
5.01
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.44
The EPS has declined by 31% year-on-year but it is up by 3.7% since the previous quarter
AGEN's equity is up by 10% YoY but it is down by 2.6% QoQ
The stock's price to sales (P/S) is 45% less than its 5-year quarterly average of 9.4 and 19% less than its last 4 quarters average of 6.3
Agenus's revenue has decreased by 41% YoY and by 3.5% from the previous quarter

Efficiency

How efficient is Agenus business performance
Agenus's return on assets has shrunk by 68% YoY but it has increased by 3.6% QoQ
The return on sales has declined by 7% since the previous quarter

Dividends

What is AGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AGEN.

Financial health

How did Agenus financials performed over time
AGEN's total assets is 50% lower than its total liabilities
AGEN's total assets is up by 38% YoY and by 4.9% QoQ
Agenus's current ratio has increased by 24% YoY and by 3.5% QoQ
Agenus's debt is 127% higher than its equity
The debt to equity has dropped by 170% year-on-year and by 42% since the previous quarter
Agenus's debt has surged by 138% YoY and by 52% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.